The complex role of tumor-infiltrating macrophages
Anthos Christofides(Beth Israel Deaconess Medical Center), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Carol Cao(Beth Israel Deaconess Medical Center), Alan T. Yeo(Boston University), Alain Charest(Beth Israel Deaconess Medical Center), Laura Strauss(AVEO Oncology (United States))
Cited by 859
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
|Science|1993|914
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
|Nature Medicine|2012|756